No Detail Found!

Clinicopathological and survival characteristics of mismatch repair status and PD-1 expression in serous ovarian cancer

Author(s)
Fatma Olmez Health Sciences University, Kanuni Sultan Suleyman Training and Research Hospital,Istanbul,Turkiye
Suleyman Cemil Oglak Health Sciences University, Gazi Yasargil Training and Research Hospital,Diyarbakir,Turkiye
Sedat Akgol Health Sciences University, Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkiye
Omer Fatih Olmez Medipol University,Istanbul,Turkiye
Ahmet Bilici Medipol University,Istanbul,Turkiye
Ozgur Akbayir Prof. Dr. Cemil Tascioglu City Hospital,Istanbul,Turkiye
Zeynep Gedik Ozkose Health Sciences University, Kanuni Sultan Suleyman Training and Research Hospital,Istanbul,Turkiye
Esra Can Health Sciences University, Kanuni Sultan Suleyman Training and Research Hospital,Istanbul,Turkiye
Omer Unal Health Sciences University, Kanuni Sultan Suleyman Training and Research Hospital,Istanbul,Turkiye
Hicran Acar Sirinoglu Prof. Dr. Cemil Tascioglu City Hospital,Istanbul,Turkiye
Abstract
Objective: To evaluate the clinicopathological characteristics of mismatch repair (MMR) de ciency and its clinical outcomes by performing immunohistochemistry (IHC) for MMR genes in the serous ovarian cancer (SOC) tumour sections. Study Design: A retrospective case-control study. Place and Duration of the Study: Gynecology Department of Kanuni Sultan Süleyman Training and Research Hospital, and Department of Medical Oncology of Medipol University, between March 2001 and January 2020. Methodology: IHC was carried out for MLH1, MSH2, MSH6, and PMS2 on full-section slides from 127 SOCs to evaluate the MMR status. MMR-negative and MMR-low groups together were de ned as MMR de cient and calledmicrosatellite instability-high (MSI-H). The MSI status and expression of programmed cell death-1 (PD-1) were compared in SOCs with di erent MMR statuses. Results: A signi cantly higher frequency of MMR-de cient SOCs was diagnosed at early stages compared with the patients in the MSS group (38.6% and 20.6%, respectively, p=0.022). The frequency of cases with PD-1 expression was signi cantly higher in the MSI-H group (76.2%) than in the MSS counterparts (58.8%, p=0.028). Patients in the MSI-H group had signi cantly longer DFS (25.6 months) and OS (not reached) than those in the MSS group (16 months and 48.9 months, p=0.039 and p=0.026, respectively). Conclusion: MSI-H SOCs were diagnosed at an earlier stage as compared to MMR pro cient cases. The presence of PD-1 expression was signi cantly higher in cases presenting MMR de ciency compared with MMR-pro cient cases. MSI status was signi cantly associated with DFS and OS.
Publication Details
Page(s) 666-672
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 33, Issue: 6, Year: 2023

Request the full text from PASTIC

Keywords
Microsatellite instability, Serous ovarian cancer, Mismatch repair de ciency
0

Citations

0

Downloads

54

Views